KIBRA attains oncogenic activity by repressing RASSF1A

Anuj1, Lakshmi Arivazhagan1, Rohan Prasad Surabhi1

  • 1Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai 600036, India.

Abstract

Insights

KIBRA protein is upregulated in breast cancer, promoting tumor growth and progression by repressing the tumor suppressor RASSF1A. This study demonstrates KIBRA's in vivo tumor-forming ability and its oncogenic mechanism.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • KIBRA, initially identified as a neuronal protein, is implicated in various cellular functions beyond the nervous system.
  • KIBRA interacts with dynein light chain 1, crucial for estrogen receptor transactivation in breast cancer.
  • KIBRA acts as a substrate for key kinases (Cdk1, Aurora, ERK), regulating cell cycle, proliferation, and migration.

Purpose of the Study:

  • To investigate the role of KIBRA in breast cancer progression.
  • To elucidate the molecular mechanisms underlying KIBRA's potential oncogenic activity.

Main Methods:

  • KIBRA expression analyzed in breast tissues and cell lines using Western blotting, IHC, and RT-PCR.
  • Stable KIBRA overexpression and knockdown cell lines generated to assess transforming properties.
  • In vivo tumorigenic efficacy evaluated through xenograft studies in nude mice.
  • Quantitative PCR array used to identify molecular targets of KIBRA.

Main Results:

  • KIBRA is significantly upregulated in breast cancer cells and tumors, correlating with disease progression.
  • Overexpression of KIBRA enhanced transforming properties in fibroblasts and breast cancer cells, while knockdown reduced them.
  • Fibroblasts overexpressing KIBRA exhibited increased tumor-forming potential in vivo.
  • RASSF1A, a known tumor suppressor, identified as a transcriptional target repressed by KIBRA.

Conclusions:

  • This study provides the first evidence of KIBRA's in vivo tumorigenic capacity.
  • KIBRA promotes cancer cell transformation by repressing the tumor suppressor RASSF1A.
  • KIBRA represents a potential therapeutic target in breast cancer treatment.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K